Abstract
BackgroundPridopidine is a S1R agonist in clinical development for HD and ALS. S1R activation by pridopidine enhances neuroprotective pathways. Increased levels of neurofilament light (NfL) protein indicate neuronal injury, serving...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
